Jonathan Nathan, MD
Plastic Surgery · Dallas, TXNPI 1134449374
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (52.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Musculoskeletal Transplant Foundation Inc. accounts for 67.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $4,641 and has fallen 91.7% since, to $387 in 2025.
Across 101 payments — averaging $142.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$10K
- AbbVie$3K
- Solta Medical, A Division Of Bausch Health US, LLC$374
- Motiva USA, LLC$173
- Regeneron Healthcare Solutions, Inc.$105
- Smith+Nephew$104
- plus $495 from 15 others
What the payments were for
- Consulting fees$7,50052%
- Travel & lodging$3,23122%
- Food & beverage$3,70526%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 28 | $9,766 |
| AbbVie(2 entities) | 40 | $3,419 |
| Solta Medical, A Division Of Bausch Health US, LLC | 5 | $374 |
| Motiva USA, LLC | 2 | $173 |
| Regeneron Healthcare Solutions, Inc. | 4 | $105 |
| Smith+Nephew | 2 | $104 |
| Galderma Laboratories, L.p. | 4 | $70 |
| Stryker | 1 | $64 |
| Johnson & Johnson | 2 | $51 |
| Misonix Inc | 1 | $48 |
| Sientra, Inc. | 2 | $41 |
| Integra Lifesciences Corporation | 1 | $38 |
| Sanofi | 1 | $25 |
| Mission Pharmacal Company | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Mentor Worldwide LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $18 |
| LEO Pharma Inc. | 1 | $17 |
| Mimedx Group, Inc. | 1 | $17 |
| Acacia Pharma Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,435 in reported general payments places this provider in the 85th percentile of 337 plastic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 12 | $44 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Dallas
- Rodney RohrichDallas$388K
- John TebbettsDallas$92K
- James SmarttDallas$91K
- Sameer JejurikarDallas$41K
- James ThorntonDallas$30K
- Jessica BilligDallas$26K
- Frederick DuffyDallas$24K
- Kent HughesDallas$24K
- Douglas SammerDallas$21K
- Phillip DauweDallas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.